Ipilimumab + Temozolomide in Metastatic Melanoma

Clinical trial NCT01119508 · COMPLETED

Trial details

NCT number: NCT01119508
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2010-05-01
Primary completion: 2016-08-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.